X-13319637-G-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001135995.2(ATXN3L):ā€‹c.298C>Gā€‹(p.Gln100Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000447 in 1,207,215 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00028 ( 0 hom., 6 hem., cov: 23)
Exomes š‘“: 0.000021 ( 0 hom. 5 hem. )

Consequence

ATXN3L
NM_001135995.2 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.78
Variant links:
Genes affected
ATXN3L (HGNC:24173): (ataxin 3 like) This intronless gene may be a pseudogene (PMID:11450850). This gene is similar to the multi-exon gene which encodes ataxin 3 and contains a coding region which could encode a protein similar to ataxin 3. Mutations in the gene encoding ataxin 3 are associated with Machado-Joseph disease. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.024434239).
BS2
High Hemizygotes in GnomAd4 at 6 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATXN3LNM_001135995.2 linkuse as main transcriptc.298C>G p.Gln100Glu missense_variant 1/1 ENST00000380622.5 NP_001129467.1 Q9H3M9B4DYC7
ATXN3LNM_001387036.1 linkuse as main transcriptc.234+64C>G intron_variant NP_001373965.1
GS1-600G8.3NR_046087.1 linkuse as main transcriptn.1953G>C non_coding_transcript_exon_variant 17/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATXN3LENST00000380622.5 linkuse as main transcriptc.298C>G p.Gln100Glu missense_variant 1/16 NM_001135995.2 ENSP00000369996.2 Q9H3M9
GS1-600G8.3ENST00000431486.1 linkuse as main transcriptn.1953G>C non_coding_transcript_exon_variant 17/171

Frequencies

GnomAD3 genomes
AF:
0.000277
AC:
31
AN:
111977
Hom.:
0
Cov.:
23
AF XY:
0.000175
AC XY:
6
AN XY:
34205
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000773
AC:
14
AN:
181170
Hom.:
0
AF XY:
0.0000446
AC XY:
3
AN XY:
67334
show subpopulations
Gnomad AFR exome
AF:
0.000970
Gnomad AMR exome
AF:
0.0000730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000210
AC:
23
AN:
1095238
Hom.:
0
Cov.:
31
AF XY:
0.0000138
AC XY:
5
AN XY:
362178
show subpopulations
Gnomad4 AFR exome
AF:
0.000720
Gnomad4 AMR exome
AF:
0.0000568
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000119
Gnomad4 OTH exome
AF:
0.0000218
GnomAD4 genome
AF:
0.000277
AC:
31
AN:
111977
Hom.:
0
Cov.:
23
AF XY:
0.000175
AC XY:
6
AN XY:
34205
show subpopulations
Gnomad4 AFR
AF:
0.00101
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000298
ESP6500AA
AF:
0.000761
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000666
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2022The c.298C>G (p.Q100E) alteration is located in exon 1 (coding exon 1) of the ATXN3L gene. This alteration results from a C to G substitution at nucleotide position 298, causing the glutamine (Q) at amino acid position 100 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
13
DANN
Benign
0.50
DEOGEN2
Benign
0.0091
T
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.95
D
M_CAP
Benign
0.0028
T
MetaRNN
Benign
0.024
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.49
N
REVEL
Benign
0.13
Sift
Benign
0.28
T
Sift4G
Benign
0.40
T
Polyphen
0.053
B
Vest4
0.21
MVP
0.29
MPC
0.081
ClinPred
0.035
T
GERP RS
-0.22
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.20
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374978755; hg19: chrX-13337756; API